Please assess the completion status of the following clinical trial:

Trial Title: TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Implanted within the last 45 days or being considered for implant with a BIOTRONIK ICD with Home Monitoring (HM)/Intracardiac Electrogram (IEGM)-Online technology, or legally marketed future generation device with HM/IEGM Online.~* Able to utilize the HM system throughout the study~* Ability to give informed consent~* Geographically stable and able to return for regular follow-ups for fifteen (15) months~* At least 18 years old~Exclusion Criteria:~* Patients who do not fulfill all inclusion criteria~* Pacemaker dependent~* Currently enrolled in any other cardiac clinical investigation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Home Monitoring (Type: ACTIVE_COMPARATOR): Home Monitoring programmed on.
- In-Office Conventional Follow-up (Type: OTHER): Home Monitoring programmed off.

Based on this trial design, predict the completion outcome and termination type (if applicable).